Volume 13 Supplement 1

29th International Symposium on Intensive Care and Emergency Medicine

Open Access

Should perioperative immune-modulating nutrition therapy be the standard of care? A systematic review

  • LB Weitzel1,
  • R Dhaliwal2,
  • J Drover2,
  • G Schiel1,
  • D Heyland2,
  • W Mayles1 and
  • P Wischmeyer1
Critical Care200913(Suppl 1):P132

https://doi.org/10.1186/cc7296

Published: 13 March 2009

Introduction

Major surgery carries a significant risk of postoperative infections, such as surgical site infections. An estimated 500,000 surgical site infections occur annually at a cost of more the $1 billion/year in the US alone. Surgical trauma leads to an initial excessive inflammatory response, together with an almost immediate and dramatic depression of cell-mediated immunity. This immnosuppression may be due to a significant decrease in plasma arginine levels observed following surgery. This arginine deficiency can severely impair T-cell proliferation and key T-cell receptor function. Perioperative arginine administration can prevent arginine deficiency and restore cellular immunity. The purpose of this meta-analysis was to examine the relationship between immune-modulating enteral nutrition therapy (IMENT) containing arginine and infectious complications, length of stay, and mortality rates in surgical patients.

Methods

All prospective randomized controlled trials of arginine-containing IMENT versus standard enteral nutrition in surgical patients conducted from 1990 to 2008 were identified from multiple databases. Studies included in the analysis evaluated infectious complication, length of stay, and/or mortality rates. Methodological quality of individual studies was scored and necessary data were abstracted in duplicate and independently.

Results

Thirty randomized trials with a total of 2,789 patients compared the use of arginine-containing IMENT with standard enteral nutrition in surgical patients. Arginine-containing IMENT significantly decreased infectious complications (relative risk = 0.58, 95% CI = 0.48 to 0.69, P < 0.00001) and overall length of stay (weighted mean difference = -2.09, 95% CI = -3.20 to -0.97, P = 0.0002) versus standard enteral nutrition. As expected in a low-mortality surgical population, however, no effect was observed on mortality (relative risk = 1.06, 95% CI = 0.60 to 1.80, P = 0.84).

Conclusion

The cumulative results show that arginine-containing IMENT significantly reduces overall infections and length of stay in surgical patients. Based on this evidence, arginine-containing IMENT could soon become the standard of care in the surgical patient. This large treatment effect demands definitive evaluation in a large multicenter trial.

Authors’ Affiliations

(1)
University of Colorado
(2)
Queens University

Copyright

© Weitzel et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement